Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $131.0000 (-3.68%) ($125.0000 - $136.0000) on Thu. Jan. 30, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1045.66% (three month average) | RSI | 81 | Latest Price | $131.0000(-3.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 31.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(8%) EWG(7%) EWI(7%) IWM(7%) JNK(7%) | Factors Impacting CAPR price | CAPR will decline at least -522.83% in a week (0% probabilities). TLT(-3%) UUP(-2%) DIA(-2%) SHY(-1%) GLD(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -522.83% (StdDev 1045.66%) | Hourly BBV | 0 () | Intraday Trend | 4.8% | | | |
|
5 Day Moving Average | $140.2(-6.56%) | 10 Day Moving Average | $131.52(-0.4%) | 20 Day Moving Average | $99.68(31.42%) | To recent high | -15.5% | To recent low | 482.2% | Market Cap | $2.58b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |